As a first step in our immune cell analysis, we assessed to what extent the CD20 cluster score was associated with abundances of CD4, CD20, or CD21-positive cells in the tumor center or the IM region, both subdivided into tumor and stroma regions (Figure S1). This evidence concerns the gene CR2 and neoplasm.